/People

Jon Edwards

Investor

General Partner at Forbion · Board director at Altesa BioSciences

Boston

Find your path to Jon

881 people in our graph can introduce you to Jon.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Pamela Klein to introduce you to Jon

You →Pamela · together at Sardona Therapeutics (2023) →Jon

Ask Jamie Chen to introduce you to Jon

You →Jamie · together at ロゴマーク:AIRNA →Jon

Ask Sam Okafor to introduce you to Jon

You →Sam · together at Medicxi →Jon

Sign up to find every way you can get introduced to Jon

  • Your email: the people you already email who know Jon
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Jon
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Jon Edwards is a General Partner at Forbion who works on sourcing, evaluating, and structuring investments spanning company creation through early clinical development across therapeutic areas. He joined Forbion in 2025 and was previously a founding team member at Red Tree Venture Capital and Medicxi, with earlier roles at ClearView Healthcare Partners and Sepracor. He completed postdoctoral research at MIT and holds a PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.

Invests in

Biotech

Board director at Altesa BioSciences

Intro paths

→

In turn, Jon can intro founders to Altesa BioSciences's investors below.

Experience

  1. ForbionGeneral Partnercurrent2026 — presentBoston, Massachusetts, United States
  2. ForbionPartner2025 — 2026Boston, Massachusetts, United States
  3. Altesa BioSciences, Inc.Board Membercurrent2026 — presentBoston, Massachusetts, United States
  4. AIRNABoard Membercurrent2026 — presentBoston, Massachusetts, United States
  5. Spolia Therapeutics, Inc.Board Membercurrent2025 — presentBoston, Massachusetts, United States
  6. RXCELERATE LIMITEDBoard Membercurrent2023 — presentCambridge, England, United Kingdom
  7. CatalYm GmbHChair of the Board of Directors2024 — 2025Munich, Bavaria, Germany
  8. SynOx TherapeuticsBoard Member2024 — 2025Ireland
  9. Bicara TherapeuticsBoard Member2022 — 2024Cambridge, Massachusetts, United States
  10. Red Tree Venture CapitalBoard Representative2023San Francisco Bay Area
  11. Red Tree Venture CapitalManaging Director2020 — 2023San Francisco Bay Area
  12. Rondo TherapeuticsBoard of Directors2022 — 2023San Francisco Bay Area
  13. Biograph55Board of Directors2023San Francisco Bay Area
  14. Sardona TherapeuticsBoard of Directors2021 — 2023San Francisco Bay Area
  15. ExcellergyBoard of Directors2021 — 2023San Francisco Bay Area
  16. medicxiPartner2018 — 2020London Area, United Kingdom
  17. medicxiPrincipal2017 — 2018
  18. medicxiAssociate2016 — 2017Geneva, Geneva, Switzerland
  19. SYDNEXISBoard of Directors2018 — 2020San Diego County, California, United States
  20. Z FACTOR LIMITEDBoard of Directors2017 — 2020Greater Cambridge Area
  21. ULTRAHUMAN LIMITEDBoard of Directors2017 — 2020Greater Edinburgh Area
  22. Checkmate PharmaceuticalsBoard of Directors2020
  23. Phathom PharmaceuticalsBoard of Directors2019 — 2020
  24. Palladio Biosciences, Inc.Board of Directors2017 — 2020Newtown, PA
  25. Synthorx IncBoard of Directors2018San Diego County, California, United States
  26. Impact Biomedicines, Inc.Board of Directors2017 — 2018San Diego County, California, United States
  27. MITResearch Affiliate2013 — 2018Greater Boston
  28. MITPost Doctoral Research Associate2012 — 2013Greater Boston
  29. Index VenturesEarly Stage Investor2014 — 2016Geneva, Geneva, Switzerland
  30. ClearView Healthcare PartnersLife Science Strategy Consultant2013 — 2014
  31. University of North Carolina at Chapel HillPh.D. UNC Chapel Hill School of Medicine - Dept. Biochemistry and Biophysics2007 — 2012Chapel Hill, NC

Skills & more

Life Sciences31Molecular Biology23Biochemistry54Medical Devices9X-ray crystallography9Product Development1Entrepreneurship7Protein Chemistry10Market Research4Marketing Strategy2Commercialization7Research15
+12 moreBiotechnologySAXSDrug DesignDrug TestingTissue CultureStructural BiologyPCRImmunohistochemistryStrategic PlanningELISANanoparticlesLifesciences

From Jon's professional profile.

Investments

Board seats

AiRNAAltesaSpoila

Investor

AltesaBicara TherapeuticsCatalYmCheckmate PharmaceuticalsExcellergyImpact BiomedicinesPalladio BiosciencesPhathom PharmaceuticalsRondo TherapeuticsRQ BioSynOx Therapeutics LtdSynthorxXenikos

Sources: the firm's website · curated public sources.

Colleagues at Forbion

Frequently asked questions

Who is Jon Edwards?
Jon Edwards is a General Partner at Forbion who works on sourcing, evaluating, and structuring investments spanning company creation through early clinical development across therapeutic areas. He joined Forbion in 2025 and was previously a founding team member at Red Tree Venture Capital and Medicxi, with earlier roles at ClearView Healthcare Partners and Sepracor. He completed postdoctoral research at MIT and holds a PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.
Where does Jon Edwards work?
Jon Edwards is General Partner at Forbion and Board director at Altesa BioSciences.
What does Jon Edwards invest in?
Jon Edwards invests in Biotech.
What boards does Jon Edwards sit on?
Jon Edwards holds tracked board seats at AiRNA, Altesa, Spoila.
What companies has Jon Edwards invested in?
Investments tracked here include Altesa, Bicara Therapeutics, CatalYm, Checkmate Pharmaceuticals, Excellergy, Impact Biomedicines, Palladio Biosciences, Phathom Pharmaceuticals, Rondo Therapeutics, RQ Bio, SynOx Therapeutics Ltd, Synthorx, and 1 more.
Where did Jon Edwards go to school?
Jon Edwards studied at The University of North Carolina at Chapel Hill (Doctor of Philosophy (Ph.D.), Biochemistry and Biophysics); University of Vermont (B.S, Biological Sciences); Massachusetts Institute of Technology (Post Doc).

Same school

Shared employers